KL
Kevin Lobo
Director

Kevin Lobo insider trades: GE HealthCare Technologies (GEHC) stock buys and sales

Director, GE HealthCare Technologies Last trade May 22, 2026 66 Form 4 filings
$0
Sold, last 12 months
0 sales
$642K
Bought, last 12 months
1 buy
14
Open-market trades
since 2013
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 22, 2026GEHC↑ Buy$642K
Nov 7, 2024SYK↓ Sell$21.1M
Nov 17, 2023SYK↓ Sell$16.3M
Dec 2, 2022SYK↓ Sell$16.1M
May 4, 2021SYK↓ Sell$27.6M
Dec 7, 2020SYK↓ Sell$2.5M
Jul 31, 2020SYK↓ Sell$4.9M
Oct 31, 2019SYK↓ Sell$4.2M
Mar 25, 2019SYK↓ Sell$8.1M
Mar 22, 2018SYK↓ Sell$6.5M
May 1, 2017SYK↓ Sell$1.3M
Nov 3, 2016SYK↓ Sell$3.0M
Mar 11, 2016SYK↓ Sell$2.7M
Aug 27, 2013PH↑ Buy$101K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other GEHC insiders

Open-market trades in the last 12 months

About Kevin Lobo's insider trades

Kevin Lobo is a director at GE HealthCare Technologies (GEHC). Since Aug 27, 2013, Kevin has reported 2 open-market purchases worth $743K and 12 sales worth $114.4M on SEC Form 4. In the last 12 months: 1 buy ($642K).

Their filings also include grants and awards (43 filings), shares withheld for taxes (21 filings), option exercises (17 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GEHC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.